Abstract
Sandhoff disease (SD) is an autosomal recessive neurodegenerative lysosomal storage disorder caused by mutations in HEXB gene. Molecular pathology is unknown in Indian patients with SD. The present study is aimed to determine mutations spectrum and molecular pathology leading to SD in 22 unrelated patients confirmed by the deficiency of β-hexosaminidase-A and total-hexosaminidase in leukocytes. To date, nearly 86 mutations of HEXB have been described, including five large deletions. Over all we have identified 13 mutations in 19 patients, eight of which were novel, including two missense mutations [c.611G>A (p.G204E), c. 634A>T (p.H212Y)], two nonsense mutations [c.333G>A (p.W111X), c.298C>T (p.R100X)], one splice site mutation c.1082+5 G>T, two small in-frame deletions [c.534_541delAGTTTATC (p.V179RfsX10), c.1563_1573delTATGGATGACG (p.M522LfsX2)] and one insertion c.1553_1554insAAGA (p.D518EfsX8). We have also identified previously known, five sequence variations leading to amino acid changes [c.926G>A (p.C309Y), c.1597C>T (p.R533C)], one nonsense mutation c.850 C>T (p.R284X), one splice site mutation c.1417+1 G-A and one insertion c.1591_1592insC (p.R531TfsX22). Mutation was not identified in three patients. We observed from this study that mutation c.850C>T (p.R284X) was identified in 4/19 (21%) patients which is likely to be the most common mutation in the country. This is the first study providing insight into the molecular basis of SD in India.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Sheth, J., Mistri, M., Sheth, F., Shah, R., Bavdekar, A., Godbole, K. et al. Burden of lysosomal storage disorders in India: experience of 387 affected children from a single diagnostic facility. JIMD Rep. 12, 51–63 (2013).
Mistri, M., Tamhankar, P. M., Sheth, F., Sanghavi, D., Kondurkar, P., Patil, S. et al. Identification of novel mutations in HEXA gene in children affected with Tay Sachs disease from India. PLoS ONE 7, e39122 (2012).
Sheth, J., Mistri, M., Datar, C., Kalane, U., Patil, S., Kamate, M. et al. Expanding the spectrum of HEXA mutations in Indian patients with Tay–Sachs disease. MGM Rep. 1, 425–430 (2014).
Seshadri, R., Christopher, R. & Arvinda, H. R. Teaching NeuroImages: MRI in infantile Sandhoff disease. Neurology 77, e34 (2011).
Jain, A., Kohli, A. & Sachan, D. Infantile Sandhoff disease with peripheral neuropathy. Pediatr. Neurol. 42, 459–461 (2010).
Nalini, A. & Christopher, R. Cerebral glycolipidoses: clinical characteristics of 41 pediatric patients. J. Child Neurol. 19, 447–452 (2004).
Unnikrishnan, A. G., Danda, S. & Seshadri, M. S. Juvenile Sandhoff Dease. Indian Pediatr. 38, 89–92 (2001).
Kaur, M. & Verma, I. C. Enzyme studies in GM2 gangliosidiosis, and their application in prenatal diagnosis. Ind. J. Pediatr. 62, 485–489 (1995).
Mittal, K., Mittal, A., Shelja, Raikwar, P. & Aggarwal, S. Infantile Sandhoff disease with hypothyroidism: a rare presentation. Int. J. Sci. Eng. Res. 5, 1455–1456 (2014).
Wendeler, M. & Sandhoff, K. Hexosaminidase assays. Glycoconj. J. 26, 945–952 (2009).
Miller, S. A., Dykes, D. D. & Polesky, H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215 (1988).
Untergrasser, A., Cutcutache, I., Koressaar, T., Ye, J., Faircloth, B. C. & Remm, M. Primer3 - new capabilities and interfaces. Nucleic Acids Res. 40, e115 (2012).
Kumar, P., Henikoff, S. & Ng, P. C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4, 1073–1081 (2009).
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A. & Bork, P. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248–249 (2010).
Schwarz, J. M., Rödelsperger, C., Schuelke, M. & Seelow, D. Mutation taster evaluates disease-causing potential of sequence alterations. Nat. Methods 7, 575–576 (2010).
Maegawa, G. H., Stockley, T., Tropak, M., Banwell, B., Blaser, S., Kok, F. et al. The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported. Pediatrics 118, e1550–e1562 (2006).
Luna, P. C., Abad, M. E., Boggio, P., Figueredo, A. M., Salgo, M., Schenone, A. et al. Lysosomal storage diseases, diagnosis from skin lesions. Dermatol. Argent. 17, 221–229 (2011).
Ashrafi, M. R., Tavasoli, A., Shiva, S., Parvaneh, N. & Tamizifar, B. Diffuse dermal melanocytosis in two patients with Sandhoff disease and mucopolysaccharidosis VI. Int. J. Dermatol. 53, 736–738 (2014).
Hackbart, B. A., Arita, J. H., Pinho, R. S., Masruha, M. R. & Vilanova, L. C. Mongolian spots are not always a benign sign. J. Pediatr. 162, 1070 (2013).
Sass, K., Wiebe, S. & Lemire, E. Infantile Sandhoff disease. SA J. Radiol. 13, 66 (2009).
Brismar, J., Brismar, G., Coates, R., Gascon, G. & Ozand, P. Increased density of the thalamus on CT scans in patients with GM2 gangliosidoses. Am. J. Neuroradiol. 11, 125–130 (1990).
Bolhuis, P. A. & Bikker, H. Deletion of the 5’-region in one or two alleles of HEXB in 15 out of 30 patients with Sandhoff disease. Hum. Genet. 90, 328–329 (1992).
Zampieri, S., Cattarossi, S., Oller Ramirez, A. M., Rosano, C., Lourenco, C. M., Passon, N. et al. Sequence and copy number analyses of HEXB gene in patients affected by Sandhoff disease: functional characterization of 9 novel sequence variants. PLoS ONE 7, e41516 (2012).
Aryan, H., Aryani, O., Banihashemi, K., Zaman, T. & Houshmand, M. Novel mutations in Sandhoff disease: a molecular analysis among Iranian cohort of infantile patients. Iran J. Public Health 41, 112–118 (2012).
Kaya, N., Al-Owain, M., Abudheim, N., Al-Zahrani, J., Colak, D., Al-Sayed, M. et al. GM2 gangliosidosis in Saudi Arabia: multiple mutations and considerations for future carrier screening. Am. J. Med. Genet A 155, 1281–1284 (2011).
Yoshizawa, T., Kohno, Y., Nissato, S. & Shoji, S. Compound heterozygosity with two novel mutations in the HEXB gene produces adult Sandhoff disease presenting as a motor neuron disease phenotype. J. Neurol. Sci. 195, 129–138 (2002).
Zampieri, S., Filocamo, M., Buratti, E., Stroppiano, M., Vlahovicek, K., Rosso, N. et al. Molecular and functional analysis of the HEXB gene in Italian patients affected with Sandhoff disease: identification of six novel alleles. Neurogenetics 10, 49–58 (2009).
Gomez-Lira, M., Sangalli, A., Mottes, M., Perusi, C., Pignatti, P. F., Rizzuto, N. et al. A common beta hexosaminidase gene mutation in adult Sandhoff disease patients. Hum. Genet. 96, 417–422 (1995).
Acknowledgements
Ethical consideration and the state of informed consent: all procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study.
Author contributions
PT, JS and MM designed the experiment and standardized the protocols. MM, PK and DS were involved in processing of the samples. PT, JS and MM prepared the manuscript. All the authors read and approved the manuscript.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Tamhankar, P., Mistri, M., Kondurkar, P. et al. Clinical, biochemical and mutation profile in Indian patients with Sandhoff disease. J Hum Genet 61, 163–166 (2016). https://doi.org/10.1038/jhg.2015.130
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/jhg.2015.130
